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ABSTRAK
Kejuruteraan tisu dijalankan untuk membaiki dan memulihkan tisu yang mengalami 
kerosakan atau dijangkiti penyakit yang seterusnya menyebabkan kecacatan 
menggunakan produk yang dicipta secara teknikal. Kemajuan dalam kejuruteraan 
tisu telah menjanjikan peluang pendekatan klinikal yang lebih baik dalam rawatan 
pesakit pergigian, terutamanya dalam bidang regenerasi endodontik, tulang dan 
tisu periodontal serta penjanaan semula keseluruhan gigi. Ulasan ini merumuskan 
kriteria pemilihan perancah yang ideal serta menpunyai potensi dalam kejuruteraan 
tisu bagi bidang pergigian. Sifat biokimia dan fizikal serta pendekatan dalam 
pembuatan perancah yang berkaitan dengan kriteria pemilihan perancah yang ideal 
untuk kejuruteraan tisu bagi bidang pergigian turut dibincangkan dalam ulasan ini. 
Ulasan ini juga membincangkan aplikasi utama kejuruteraan tisu dalam bidang 
pergigian, seterusnya mewujudkan paradigma untuk kajian penjanaan semula tisu 
tulang pada masa hadapan menggunakan sel dan perancah yang tertentu sebagai 
rawatan alternatif dalam pergigian.
Kata kunci: bahan bioserasi, kejuruteraan tisu, pergigian, sel stem
ABSTRACT
Tissue engineering aims to restore lost, damaged, diseased or defective tissues in 
the human body using engineered or regenerated products. The advancement of 
tissue engineering has given a promising opportunity for better clinical practice in 
treating dental patients especially in the fields of endodontic, bone and periodontal 
tissue as well as whole tooth regeneration. In this review, we briefly summarise the 
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possible selection criteria of scaffolds for potential tissue engineering applications 
in dentistry. Biochemical and physical properties, as well as scaffolding approaches 
involved in the selection of an ideal scaffold for dental tissue engineering, are also 
discussed in this review.  This review also discussed major applications of tissue 
engineering in the dentistry field, which can create a paradigm for future studies of 
tissue regeneration by using selected cells and scaffolds as an alternative treatment 
in dentistry.
Keywords: biocompatible material, dentistry, stem cells, tissue engineering
main groups based on their embryonic 
origin (Chieruzzi et al. 2016; Sharpe 
2016): pluripotent stem cells, 
mesenchymal stem cells, and epithelial 
stem cells. Pluripotent stem cells, for 
instance, is dental pulp pluripotent 
stem cells (DPPSC). Mesenchymal 
stem cells consist of dental pulp stem 
cells (DPSC), stem cells from human 
exfoliated deciduous teeth (SHED), 
stem cells from apical papilla (SCAP), 
and stem cells from periodontal 
ligament (PDLSC). The cells, which 
reside in the developing tooth germ, 
oral epithelium, and salivary gland 
appear to be in the group of epithelial 
stem cells.
 Advances in the field of cellular 
and molecular biology have allowed 
the exploration of growth factor 
functions and their participation 
in the regenerative approach. 
Several commonly used biological 
mediators are intended to induce and 
accelerate cell growth in dental tissue 
engineering, such as (Chieruzzi et al. 
2016) i.e. (i) Periodontal regeneration: 
fibroblast growth factor-2, platelet-
derived growth factor (PDGF), vascular 
endothelial growth factor (VEGF); 
(ii) Pulp-dentin complex: Stromal 
INTRODUCTION
The field of tissue engineering has 
dramatically evolved in the past 
decades, offering a potential paradigm 
shift in the current management of 
diseases involving tissues and organs 
of the human body and ultimately 
improve the patient’s quality of life. 
In the dental field, a possible area 
of implementing tissue engineering 
is coming to the fore: regenerative 
endodontics, regeneration of bone for a 
bony defect, periodontium composed 
of complex cementum, periodontal 
ligament tissues and alveolar bone and 
regeneration of the whole tooth. 
 Generally, the triad of stem cells-
scaffolds-growth factor plays an 
important role in the success of 
tissue engineering and regenerative 
medicine. The stem cells can either 
be of dental or non-dental origin. 
Stem cells from bone marrow, adipose 
tissue, and induced pluripotent stem 
cells are among non-dental origin 
widely used in tissue engineering 
(Chieruzzi et al. 2016; Ude et al. 2018). 
Dental stem cells are more of interest 
due to their affinity with target tissues. 
They have been categorized into three 
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cell-derived factor-1, basic fibroblast 
growth factor, PDGF, stem cells factor
 Scaffolds are biomaterials, matrices, 
or constructs (Chen & Liu 2016) that 
act as artificial frameworks to guide 
the growth of intended tissues. In 
the past few decades, biomaterial for 
biomedical application has progressed 
significantly. This review highlights 
various scaffolds that previous 
researchers have explored for tissue 
engineering in dentistry. 
SCAFFOLDS IN TISSUE 
ENGINEERING
A scaffold is a biomaterial that provides 
an environment that allows implanted 
cells to proliferate, differentiate, and 
form the intended tissue or organ 
(Chen & Liu 2016). It is designed to 
perform the following functions i.e. (i) 
promote interaction of cell-biomaterial 
state, cell adhesion and deposition of 
extracellular matrix (ECM); (ii) allow 
transportation of nutrients, gases, 
and factors for a cell to survive, 
proliferate and differentiate; (iii) able to 
biodegrade at a controllable rate with 
tissue regeneration; and also (iv) exhibit 
a minimal degree of inflammation. 
It can be classified according to their 
structural, chemical and biological 
characteristics (Chen & Liu 2016). In 
general, scaffolds are divided into three 
groups; natural polymers, synthetic 
polymers, and bioceramics. 
 Natural polymer scaffolds enhance 
the performance of cells in the 
biological environment since they 
have better interaction due to their 
bioactive properties (Proksch & 
Galler 2018). Natural scaffolds can be 
obtained from natural sources. Natural 
scaffolds are categorised into proteins, 
polysaccharides or nucleic acids (DNA 
and RNA) (Proksch & Galler 2018; Kelly 
et al. 2019). Moreover, some natural 
scaffolds that are actively being used 
in dental tissue regeneration include 
proteins like collagen, gelatin, fibrin, 
and silk as well as polysaccharides 
like chitosan, hyaluronic acid, alginate, 
and agarose. These scaffolds usually 
have excellent biocompatibility for 
cell attachment and proliferation. 
Nevertheless, the use of this type 
of material for load-bearing areas is 
limited by its physical and mechanical 
instability (Proksch & Galler 2018).
 Synthetic polymers have the 
advantages of being predictable 
and have reproducible physical and 
chemical properties (i.e. porosity, 
tensile strength, elastic modulus, 
degradation time). These types of 
scaffolds also exhibit physicochemical 
and mechanical properties comparable 
to biological tissues. They can also 
be manufactured under a controlled 
condition that allows production in 
a larger scale of uniform size and 
design, making them very useful for 
biomedical applications (Proksch 
& Galler 2018; Dorati et al. 2017).  
Examples of synthetic scaffolds are 
organic polymers like polylactic 
acid (PLA), polyglycolic acid (PGA), 
poly lactide-co-glycolic acid (PLGA), 
and polycaprolactone (PCL). PLGA 
and PCL are a few polymers that are 
commonly used for forming scaffolds 
in dental tissue regeneration.
 Bioactive ceramics such as 
hydroxyapatite (HA) and tricalcium 
phosphate (TCP) are often associated 
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with insufficient biocompatibility 
and biodegradability, limiting the 
clinical use of this type of scaffold in 
tissue engineering (Chocholata et al. 
2019). Researchers have overcome 
this issue by combining synthetic 
and natural polymers to enhance 
the aforementioned properties. This 
type of material is generally known 
as a composite. Composite materials 
include a polymer phase with toughness 
and compressive strength, and an 
inorganic phase with bioactivity, which 
improves the mechanical properties 
and degradation rate (Chocholata 
et al. 2019). Composite scaffolds of 
PLGA/HA, PLGA/TCP, PCL/PGA, and 
zirconia/HA are commonly used in 
dentistry.
Biochemical Property
Immunogenicity and biocompatibility
These issues usually relate to natural 
scaffolds since they are obtained 
from allogenic or xenogenic sources, 
which may be antigenic to the host 
and could cause the body to exhibit 
an immunologic reaction to the 
scaffold, an inflammatory response, 
and cytotoxicity to native cells, 
tissues, or organs. Reconstruction 
of the craniofacial defect using a 
xenograft scaffold usually results in 
disease transmission and stimulation 
of immunogenicity. Therefore, it 
is necessary that the scaffold used 
in the reconstruction of dental 
tissue exhibit minimal or avoid host 
immune responses. The immune-inert 
scaffolds concept was just recently 
implemented. These scaffolds have 
an immune-modulatory function that 
regulates the immune system (i.e., 
decreased natural killer cell activity 
and T-and-B-cell-mediated immunity) 
(Roseti et al. 2017).
 Since the scaffold is expected to 
remain in the human body and lasts 
for some time, bi-products resulting 
from the degradation process of the 
scaffold should not produce any 
harmful material or element in the 
body. The scaffold should be able to 
biodegrade in vivo at a certain time 
that matches with the new matrix 
production of the developing tissue 
upon implantation (Nelms & Palmer 
2019), with a controllable absorption 
rate that eventually provides space for 
new tissue generation (Yi et al. 2016). 
The degradation of the biomaterial 
should allow the intended tissue to 
generate, for instance in spinal fusion, 
with the requirement being after nine 
months or longer while the skull or 
maxillofacial bone required three 
to six months’ degradation (Yi et al. 
2016). Moreover, for pediatric patients 
with mandible defects, future growth 
of the mandible must be considered. 
In this case, fixation of the mandible 
using scaffolds without biodegradable 
properties prevent mandibular 
growth over time and could result 
in facial asymmetry and problems 
with occlusion as the patient grows 
(Kakarala et al. 2018). Therefore, recent 
criteria for ideal scaffold design and 
development require that scaffolds 
naturally degrade at an appropriate rate 
so that there is enough time for bone 
regeneration, and gradual absorbtion 
by the human body without generating 
any side effects.  
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Physical Property
Porosity (pore volume fraction of 
scaffold)
The scaffold should offer a void 
volume for neovascularization, new 
tissue formation, and remodelling 
to promote integration with the host 
tissue upon implantation (Iviglia et 
al. 2019). The scaffold should also 
have enough porosity for effective 
nutrient and metabolite transportation 
and exchange with the surrounding 
environments. A porous scaffold is 
essential i.e. i) in the proliferation and 
migration of new tissue formation 
and vascularization, ii) to assist 
mechanical interlocking between the 
scaffold and environment for stability, 
as well as iii) to facilitate, guide, and 
promote the formation of new tissues 
(Iviglia et al. 2019). However, the 
mechanical properties of scaffolds are 
inversely related to porosity. Hence, an 
adequate balance between porosity 
and mechanical properties should be 
considered when designing an ideal 
scaffold. 
Pore size (pore diameter)
Pore size would have a direct impact 
on the functionality of the scaffold 
during application. For bone tissue 
engineering, the ideal pore size is still 
a subject of debate among researchers 
due to conflicting reports. For instance, 
a pore size >200 μm is reportedly 
required for osteoconduction and up 
to 500 μm for vascularization (Cheng 
et al. 2016). This is due to the nature of 
the cell-forming bone, osteoblast. As 
osteoblast is approximately 10-50 μm, 
in size, but scaffolds with larger pores 
sizes of 100-200 μm are preferred for 
the osteoblast to regenerate mineralised 
bone after implantation (Abbasi et al. 
2020). This larger pore size permits 
macrophages to infiltrate, eliminate 
bacteria, and induce cells colonisation, 
migration, and vascularisation in 
vivo (Iviglia et al. 2019). Meanwhile, 
a smaller pore size of <100 μm 
reportedly promotes the formation 
of non-mineralised osteoid or fibrous 
tissue (Iviglia et al. 2019; Liu et al. 
2018). Cheng et al. (2016) reported that 
scaffolds with a larger pore size caused 
a greater formation of mature bone by 
promoting vascularisation, these newly 
formed blood vessels supply sufficient 
oxygen and nutrients, thus promoting 
better osteoblastic activity. However, 
cell-seeded scaffolds with a pore size 
greater than 500 μm might be washed 
away during in vivo application. 
Hence, the appropriate pore size 
should be within the range of 200-
500 μm for better differentiation and 
vascularization.
Interconnectivity 
The interconnectivity feature is 
essential to enable cell migration 
and perfusion without a severe 
concentration gradient in the scaffold 
that may finally end up in cell death 
and tissue necrosis (Guda et al. 2014). 
Additionally, interconnectivity also 
provides space for cell metabolism 
(i.e. to nourish new bone and remove 
wastes) via vascular development. A 
lack of pore interconnection will result 
in a poor or low efficiency of changes 
in nutrients, gas, and waste within the 
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scaffolds. It is preferable that scaffolds 
for dental tissue engineering have a 
100% interconnecting pore volume, 
thereby also maximizing the diffusion 
and exchange of nutrients throughout 
the entire scaffold pore volume.
Mechanical Property
The scaffolds used in dental tissue 
engineering should have mechanical 
properties consistent with the 
anatomical properties of the implanted 
place and should have a strong and 
good working ability with hand tools. 
Since a tooth is routinely subjected to 
mechanical loads, scaffolds selected 
for regenerating dental tissues must 
have adequate strength properties to 
support the applied loads. Moreover, 
sufficient mechanical strength is 
crucial to maintain cell integrity until 
new tissues form. Aside from affecting 
the cell behavior and differentiation 
potential, the porosity and pore 
sizes of the scaffolds also affect their 
mechanical properties. Intensive 
porosity and pore sizes may facilitate 
nutrient and oxygen delivery or 
enable more cell ingrowth, which may 
compromise the mechanical properties 
of the scaffold due to a large volume 
size (Farzin et al. 2019). Although the 
mechanical property of scaffolds is 
effected by intensive porosity or pore 
sizes, the use of materials with high 
inherent mechanical strength might 
be a solution to this issue. Moreover, 
it is important that the material 
property of the scaffolds matches 
the native tissue in vivo, especially 
for bone regeneration as new bone 
should withstand loadings to prevent 
stress shielding, comparable to the 
surrounding native bones. Thus, the 
mechanical property of the intended 
tissue to be grown should be taken 
into consideration when designing 
pore size and porosity, both of which 
should be incorporated into a scaffold. 
SCAFFOLD DESIGN 
Major scaffolding approaches have 
evolved these last few decades 
especially in the area of tissue 
engineering including pre-made 
porous scaffold, decellularised 
extracellular matrix (ECM), cell sheets 
with secreted ECM, cell encapsulated 
in self-assembled hydrogels, and rapid 
prototyping. 
Pre-made Porous Scaffold
This type of scaffold is the most well-
established and commonly used 
scaffold in tissue engineering (Mallick 
et al. 2015). Natural and synthetic 
scaffolds are used for manufacturing 
porous scaffolds. Since this approach 
relatively offers a precise design for 
tissue architecture and microstructure, 
the physicochemical properties are 
easily engineered to mimic the native 
ECM in the host tissue. This aids load-
bearing tissues where the mechanical 
properties are important (Mallick et 
al. 2015; Johari et al. 2017). However, 
various efforts have been made to 
overcome the limitation of the cell’s 
ability to penetrate the scaffold 
without increasing production cost 
or cell viability. Pre-made porous 
scaffolds have also has been applied in 
dentistry, mainly for the regeneration of 
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augmenting atrophic ridges. One of the 
greatest challenges facing successful 
ridge augmentation is to maintain 
the desired shape after soft tissue 
closure (D’Amato et al. 2015). Several 
studies have reported a high rate of 
bone resorption after the insertion of 
a pre-made porous scaffold in bone 
augmented ridges (Aboushelib & 
Shawky 2017; Berberi & Nader 2016).
Decellularised Extracellular Matrix
Acellular ECM is developed after the 
removal of the cellular component from 
allogenic or xenogenic tissue using a 
combination of physical, chemical, 
and enzymatic approaches while 
preserving the natural composition 
of the basic structural and functional 
ECM proteins. This approach is 
popularly used for tissue engineering 
involving heart valves, vessels, nerves, 
tendons, and ligaments (Parmaksiz 
et al. 2016). Scaffolds fabricated with 
this technique are assumed to have 
better immunologic properties as 
cellular antigens where the sources 
for immunogenic reaction have been 
removed and replaced with more 
natural mechanical and biological 
properties. Besides that, preserved 
growth factors in the decellularised 
matrix are also an advantage to facilitate 
further cell growth after implantation. 
In dentistry, this approach may work 
through a combination of acellular 
products with graft material for 
treatments of maxillofacial defects, the 
soft connective tissue of the mouth, 
and intra-oral mucosal damages 
(Parmaksiz et al. 2016).  In a recent 
study performed with Alloderm®, 
an acellular collagen matrix derived 
from a decellularised human dermis, 
researchers reported significant 
improvement in gingival repair by the 
end of the nine-month observation 
period (Agarwal et al. 2015).   
Cell Sheets with Secreted ECM
This scaffolding approach, using 
confluent cells coated on a culture dish, 
is harvested from thermos-responsive 
polymers without the use of scaffolds 
(Iwata et al. 2015). The advantage of 
this approach is the ability to keep 
ECM proteins and cell-cell interaction 
intact during implantation. Apart from 
that, this process can be repeated to 
form a thicker matrix with multiple 
laminations of single cells. A variety 
of cell sheets with secreted ECM are 
applied in tissue engineering, for 
instance, using the cell sheet as a source 
of 3 dimensional (3D) pellet, applying a 
multi-layered cell sheet, and using the 
cell sheet to wrap a scaffold (Paz et al. 
2018). This approach has been applied 
for the regeneration of soft tissue such 
as cornea and myocardium in the 
biomedical area; with several attempts 
to produce periodontal apparatus to 
treat periodontitis in dentistry. The 
tissues rich in ECM for load-bearing 
purposes (bones and cartilage) are 
almost impossible to manufacture with 
this type of engineering, as the amount 
of secreted ECM is limited (Paz et al. 
2018).
Cell Encapsulated in the Self-
Assembled Hydrogel
Encapsulation is a process of entrapping 
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cells within a semi-permeable 
membrane or a homogenous solid 
mass (Kim et al. 2019). Hydrogels are 
the most commonly used materials 
for encapsulation; derived from either 
natural (algae, alginate, agarose, and 
chitosan) or synthetic (polyethylene 
glycol and polyvinyl alcohol) sources. 
Cell encapsulated hydrogel allows 
cells to retain a structurally supported 
scaffold for cell proliferation and 
subsequently degrade when the 
cells secrete ECM (Johari et al. 2017). 
This scaffolding approach is most 
commonly applied in engineering 
heart muscles, neural, and liver for 
biomedical applications. Meanwhile, 
the regeneration of new dental pulp to 
treat necrotic teeth has been actively 
applied in dentistry. For example, 
Gelfoam-encapsulated dental stem 
cells are actively applied for treatment 
to regenerate new dental pulp tissue 
(Kaur et al. 2016). The advantage 
of this approach is simple, yielding 
homogeneous cell distribution 
and enormous viability (Kim et al. 
2019). Nevertheless, due to the poor 
mechanical properties of hydrogels, its 
application in tissues with load-bearing 
functions is rare. 
Rapid Prototyping
This approach involves fabricating a 
scaffold directly from a scanned image 
and a computer model of the defect site 
(Yuan et al. 2017). Rapid prototyping 
approaches produce scaffolds that are 
structurally and mechanically precise 
to defect sites. The rapid prototyping 
approach has quickly gained 
popularity in bone tissue engineering 
for its high precision, reproducibility, 
and controllable pore structure. The 
term “3D printing”, which is the most 
popular to the public, refers to rapid 
prototyping (Yuan et al. 2017). In 
3D printing, scaffold materials are 
manufactured layer by layer to form a 
3D model, thus enabling better control 
of a scaffold’s physical properties. 
Many polymers are printable, for they 
often have proper melting ranges 
require to shape scaffolds. PLA, PCL, 
PLGA, and porous ceramic are types 
of scaffold materials usually fabricated 
using 3D printing. In dentistry, 
fabricating a scaffold for maxillofacial 
bone, a temporal mandibular joint 
disc, a tooth, or periodontal tissue are 
major applications of this approach 
(Yuan et al. 2017). 
SCAFFOLD AND TISSUE 
ENGINEERING IN DENTISTRY
The emergence of tissue engineering 
in a multidisciplinary field sheds new 
light on the treatment of patients. In 
dentistry, tissue engineering offers the 
regeneration of non-dental tissues 
and dental tissues as well as their 
supporting structures. There are three 
main areas of tissue engineering that 
have been extensively studied for 
dental application: the regeneration of 
pulp-dentin complex, the regeneration 
of bone, and the regeneration of 
periodontal tissue.
Regeneration of Pulp-dentine 
Complex
Regenerative endodontics refers 
to “biologically-based procedures 
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designed to replace damaged 
structures, including dentin and root 
structures, as well as the cells of 
the pulp-dentin complex’’ (Murray 
et al. 2007). This new treatment 
modality utilizes the concepts of 
tissue engineering to restore the canal 
system and surrounding tissue to a 
healthy state, thus allowing the root 
to continue to develop. Regeneration 
implies proper re-vascularisation 
and re-innervation of the pulp thus 
permitting the formation of new dentin 
(Mitsiadis et al. 2015). 
 It might be possible to treat pulpal 
necrosis by generating new dental 
pulp, in particular, the functional 
dentin-making odontoblast and 
vascular endothelial cells. One 
challenge of manufacturing scaffolds 
for this application is the small and 
enclosed space of the root canal 
environment. In the regeneration of 
a pulp-dentine complex, the scaffold 
should have a relatively fast setting 
time (Ajay Sharma et al. 2015). The 
use of a soft and injectable scaffold 
to engineer the pulp-dentine complex 
is an advantage due to its small size 
and the difficulty of reaching the 
receiving site (Chieruzzi et al. 2016). 
The Puramatrix™ hydrogel scaffold 
has been used successfully in a tooth 
slice model (Cavalcanti et al. 2013; 
Dissanayaka et al. 2015) and full-length 
human root canals (Rosa et al. 2013), 
as shown in Table 1. Since vascular 
endothelial cells are equally important 
as odontoblast in regenerative 
endodontics, Dissanayaka et al. (2015) 
utilized prevascularized PuraMatrix™ 
using human umbilical vein endothelial 
cells (HUVEC). This in vivo study 
showed promising histological results 
for both odontogenic and angiogenic 
processes. Despite the success, the 
prevascularised PuraMatrix™ showed 
limited ability to regenerate pulp-
like tissue up to the middle (5 mm) 
to lower third (3.3 mm) of the root 
canal, as shown in Table 1. Thus, this 
method can only be applied for pulp 
regeneration in a tooth with an open 
apex. However, the biggest problem of 
utilizing HUVEC in pulp regeneration 
is the risk of an immunologic reaction 
to the host. 
 A recent of regenerative endodontics 
approach that has been successfully 
applied in a clinical setting is based 
on the bleeding technique, whereby 
the blood clot will act as a scaffold 
to deliver the stem cells into the root 
canal system. Platelet concentrates 
are also a source of growth factors 
that are essential in tissue engineering 
(Bakhtiar et al. 2017). The use of the 
first generation of platelet concentrates, 
platelet-rich plasma (PRP) as a 
scaffold in regenerative endodontics 
has been evaluated clinically and 
radiographically showing no significant 
difference in the success rate between 
PRP and a conventional blood clot 
(BC) scaffold, as shown in Table 1 
(Bezgin et al. 2015). However, this 
technique has a complex production 
procedure, activation, and sudden 
fibrin polymerization as it requires 
thrombin as coagulation agents. 
This may predispose the donor to 
an immunologic reaction. Thus, 
platelet-rich fibrin, which are second-
generation platelets, was introduced 
to overcome the disadvantages of PRP. 
As shown in Table 1, the clinical and 
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radiographical evaluation of four case 
series demonstrated a positive outcome 
for all cases, i.e.: the resolution of 
periapical lesion, continuous root 
development, and apical closure after 
18 months recall in immature teeth 
with necrotic pulps (Bakhtiar et al. 
2017). 
 The platelet concentrates technique, 
particularly the platelet-rich fibrin 
clots, is one of the possible successful 
scaffolds for regenerating pulp 
complex tissue. However, this method 
requires an additional phlebotomy, 
a procedure which is uncomfortable 
for children. In these cases, injectable 
hydrogel scaffolds are more practical 
perhaps with further clinical trials to 
provide concrete evidence for pulp 
regeneration. The use of soft injectable 
hydrogels into a narrow tapering canal 
is an advantage. Nevertheless, the 
whole process is quite tedious and 
time-consuming if it is to be translated 
into clinical application. Thus, the 
choice of scaffolds will depend on the 
clinicians' clinical assessment of the 
patient’s age, level of cooperation, and 
stage of root development. 
Regeneration of Bone
The current practice in treating cranial 
and maxillofacial defects involves the 
use of autologous bone. However, this 
treatment modality brings together a 
few disadvantages; a second surgery in 
the donor site with limited shape and 
some bone pain, swelling, infection, 
and scarring (Shamsuddin et al. 2017; 
Farré-Guasch et al. 2015). Thus, the 
concept of bone tissue engineering 
could bring a paradigm shift to the 
gold standard of autologous bone in 
treating a bone defect in this area. 
Nevertheless, constructing a potential 
bone replacement that is structurally, 
functionally and mechanically 
comparable to the natural bone 
in treating bone defect has been a 
challenge thus far.  
 Bone tissue engineering applies the 
concept of seeding osteogenic cells into 
an osteoconductive scaffold together 
with the induction of angiogenesis to 
regulate the metabolism of the cells 
(Shamsuddin et al. 2017; Khojasteh 
et al. 2016). This scaffold should be 
biocompatible and porous to allow the 
migration, adhesion, proliferation, and 
differentiation of seeded mesenchymal 
cells into an osteoblast. The 
biodegradable property of scaffolds 
allows the deposition of new bone 
(Huang et al. 2018).  A scaffold with a 
well-interconnected structure enables 
the acceleration of bone regeneration 
and vascularization (Sarker et al. 2015). 
As in other fields of tissue engineering, 
extensive works have been conducted 
in search of suitable scaffolds for bone 
engineering over the past decades. 
This effort included the use of natural, 
synthetic, bioceramic, platelet-
concentrated materials as well as 
mixed composites for different scaffold 
designs.
 Apart from application in soft tissue 
engineering, natural hydrogel such as 
gelatin is a potential scaffold for non-
load-bearing bone regeneration due to 
their low mechanical modulus (Jaipan 
et al. 2017). Gelatin, a protein obtained 
from the hydrolysis of collagen, has 
been an attractive candidate for 
fabricating natural hydrogel due to its 
47
Tissue Engineering in Dentistry Med & Health Jun 2020;15(1): 34-53
large number of functional groups that 
can be easily crosslinked. Nevertheless, 
recent studies have introduced 
crosslinking between genipin and 
gelatin to increase gelatin stiffness, 
support differentiation, mineralisation, 
increase stability during implantation, 
as well as significantly inhibit bacterial 
proliferation (Nguyen et al. 2016; 
Muhammad Mior et al. 2019; Chang et 
al. 2019; Sun et al. 2016).  
 Fibrin, the essential element 
in clotting and wound healing is 
biodegradable and degrades within 
two weeks after implantation (Li et al. 
2015). The use of fibrin glue in a large 
animal model showed significant new 
bone formation in a surgically prepared 
alveolar cleft (Yuanzheng et al. 2015). A 
similar promising result was found in a 
recent study in which relatively higher 
new bone formation was observed 
eight weeks after implantation (Wang 
et al. 2017). Despite this success, the 
latter study utilized amniotic fluid-
derived stem cells-premixed with PRP 
gel as compared to bone marrow 
stem cells in the former study. Wang 
et al. (2017) postulated the positive 
synergistic effect of PRP, which could 
be attributed to the angiogenetic, 
proliferative and differentiating effect 
of the growth factor contained in PRP. 
 Several bioceramic scaffolds from 
both calcium phosphate-based and 
glass-ceramic groups have been 
investigated. HA and β-TCP are among 
the most studied scaffolds in the former 
group. HA is the commonly investigated 
material among researchers as this 
scaffold shares a similar mineral 
structure with bone. HA scaffolds with 
pore sizes ranging from 50 μm to 1000 
μm have been investigated both in vivo 
and in vitro (Guda et al. 2014; Quinlan 
et al. 2015). The consensus remains 
that for osteogenesis, a  pore size of 
more than 100 μm is recommended, 
whereas to support vascularization, 
a pore size of more than 300 μm is 
required (Guda et al. 2014). Since 
interconnectivity is also among the 
important features of a scaffold, 
Guda et al. (2014) demonstrated 
that larger interconnecting uniform 
pores (400+40 μm) had greater bone 
regeneration, mechanical strength, 
and toughness in large segmental 
defect, as shown in Table 1. However, 
the study was conducted on a long 
bone defect, which may not be a 
true reflection of the cranial bones 
that are flatter and thinner. Despite 
excellent osteoconductivity, concerns 
have been raised regarding the limited 
biodegradation and bioresorbability 
properties of HA (Huang et al. 2018). 
This means HA tends to remain in the 
body for a long time after implantation. 
HA is also associated with hardness, 
fragility, and a lack of flexibility. Hence, 
their application in a situation in which 
the scaffold is required to be shaped 
in a specific form is limited (Chang et 
al. 2013). In addition, HA is also is not 
an option in large bone regeneration 
due to brittleness and low mechanical 
stability (Huang et al. 2018). 
Alternately, being one of the most 
extensive forms of TCP used in tissue 
engineering, β-TCP has been proven 
to have good biocompatibility and 
faster degradation than HA but causes 
brittleness, poor fatigue resistance, and 
is difficult to shape (Huang et al. 2018, 
Arahira et al. 2015). 
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 Many studies have reported on 
composite materials containing a 
combination of two or more groups of 
scaffolds to overcome the drawbacks of 
each component. Shavandi et al. (2016) 
reported that the biocompatibility 
and mechanical property of HA was 
improved after nanohydroxyapatite 
with a pore size of 10-30 nm was 
incorporated into chitin hydrogel. 
Poly-ɛ-caprolactone (PCL), a synthetic 
scaffold, presents long degradation 
times and poor bioactivity (Huang et 
al. 2018). Huang et al. (2018) suggested 
the incorporation of a mixture of HA 
and TCP into a PCL scaffold as an 
ideal composite scaffold for bone 
regeneration. However, a mixture of 
HA showed a better result compared 
to TCP (Huang et al. 2018). Shim and 
co-worker (2017) manipulated the PCL 
structure by adding TCP to increase the 
mechanical yield strength of the brittle 
PCL. The PCL scaffold alone is usually 
fabricated with 80% porosity and a 0.2-
1 mm pore size, which is slightly bigger 
than the commonly used scaffolds in 
bone engineering. Although the study 
successfully generated bone, the  main 
concern was the possibility of seeded 
cells washing out during in vivo 
application (Shim et al. 2017). 
 As shown in Table 1, Khojasteh 
et al. (2016) conducted a study by 
coating PLGA on highly porous β-TCP 
and encapsulating it with VEGF with 
an average pore size of about 500 
μm. The highly porous β-TCP coated 
with PLGA resulted in a scaffold 
with increased compressive and 
mechanical strength (Khojasteh et al. 
2016). Granular β-TCP was used in 
a chin reconstruction case due to its 
resorption profile (De Ruiter et al. 2015). 
β-TCP degraded faster as compared 
to crystalline hydroxyapatite but had 
low mechanical properties due to its 
brittleness; which in turn, may cause a 
sudden collapse of newly formed bone 
(Arahira et al. 2015). Bone regeneration 
in cleft patients utilizing mesenchymal 
stem cells (MSC) loaded on HA/β-TCP 
scaffolds with a combination of PDGF 
has shown successful bone formation 
3-months postoperatively (Du et al. 
2017), as shown in Table 1. However, 
the disadvantages of this study are a 
lower amount of regenerated bone as 
compared to the autogenous iliac graft 
and the absence of a control group for 
comparison due to ethical issues. 
 A natural hydrogel can be considered 
an option for bone regeneration in a 
non-load-bearing area. Platelet-derived 
concentrates could also serve as an 
alternative scaffold since the effect of 
the growth factor in PRP contributes 
to the angiogenesis, proliferation, 
and differentiation of cells. For load-
bearing areas, the use of bioceramics 
is preferred since this type of scaffold 
offers better mechanical properties 
for the intended tissue growth. The 
initiative of mixing bioceramic material 
into a synthetic scaffold improves the 
biological and physical property of 
the scaffold which would enhance 
cell attachment, proliferation, and 
differentiation. Hence, the most 
suitable type of scaffold for bone 
regeneration will depend on the site 
and the size of the intended tissue to 
growth. 
 Regeneration of periodontal tissues
Periodontitis is an inflammatory disease 
that may lead to the destruction of 
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the periodontal tissue. The treatment 
modalities include non-surgical 
treatment and periodontal surgery. 
The ultimate goal for successful 
periodontal regeneration consists of a 
newly formed functional periodontal 
ligament between the regenerated 
cementum on the root surface and the 
newly formed alveolar bone. To achieve 
this successful clinical outcome, a 
coordinated response between the 
soft tissue (periodontal ligament and 
gingiva) and hard tissue (alveolar bone 
and cementum) component during 
wound healing is required (Ivanovski 
et al. 2014). The current approach 
for treating this periodontal disease is 
by using guided tissue regeneration 
which utilises a membrane barrier to 
allow the selective repopulation of the 
periodontal defect by cells from the 
remaining periodontal ligament (Chen 
et al. 2016). This treatment modality 
is only applicable to a limited range 
of clinical scenarios such as with 
infrabony defects and mandibular 
molar Class II bifurcation involvement 
(Ivanovski et al. 2014). Generally, 
scaffolds in tissue engineering should 
degrade and resorb as the new tissue 
regenerates. However, periodontal 
regeneration involves different tissues 
and it is important to note that ingrowth 
and maturation differ between tissues 
(Ivanovski et al. 2014). Chen and Liu 
(2016) suggested that scaffolds should 
remain intact to allow newly formed 
tissues to mature inside the pores while 
degradation takes place at a later time.
In periodontal regeneration, 
the scaffold design is equally as 
important as the type of scaffold. 
Researchers have investigated 
various techniques and approaches 
including compartmentalised designs, 
computer-aided design based on 
compartmentalised scaffolds and cell 
sheet technology. The double-layered 
scaffold approach is a modification 
of the traditional guided tissue 
regeneration technique; the outer 
phase is designed as an occlusive 
membrane preventing the invasion of 
surrounding tissue into a periodontal 
defect while the inner phase is 
manufactured with macropores to suit 
bone regeneration (Requicha et al. 
2014), as shown in Table 1. Requicha 
et al. (2014) reported a positive 
outcome in their bilayered scaffold 
manufactured via a combination of 
starch and a slower degrading polymer, 
PCL. The results demonstrated the 
osteogenic differentiation of seeded 
cells, which are part of the essential 
structure of periodontium, while 
the membrane layer promoted cell 
attachment and proliferation. Because 
the canine adipose stem cells used 
grow preferentially on the fiber mesh, 
the distribution of cells into the interior 
part is limited so their viability is 
affected (Requicha et al. 2014). 
 An extensive work by Park and 
co-workers (2014) on a multi-phasic 
scaffold demonstrated the role of 
computational design and 3D printing 
in periodontal tissue regeneration, 
as shown in  Table 1. The designed 
fiber-guiding scaffolds promoted 
the formation and orientation of 
Periodontal Sharpey’s fiber i.e. Type-I 
collagen bundles embedded within 
the cementum and alveolar bone that 
respond to mechanical forces (Park et 
al. 2014). However, these fiber-guiding 
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scaffolds may increase the treatment 
cost because of the use of computer 
technology. Well-trained personnel are 
also required to deliver this treatment 
to the patient. 
 The promising results from various 
studies serve as a foundation for a 
future paradigm shift in treatment 
modalities for periodontal diseases; 
from replacement to regeneration. 
Nevertheless, due to the complexity 
of the periodontal tissue, the 
development of suitable scaffolds is 
also challenging. The recent approach 
of using compartmentalised scaffolds 
seems successful but brings together 
disadvantages of cost and training 
issues in clinical application. 
CONCLUSION
Scaffolds are an important component 
of tissue engineering. The scaffold 
used in dental tissue engineering must 
exhibit minimal immune response. It 
must also be biocompatible with an 
appropriate degradation rate, have 
adequate porosity, and a pore size 
with a 100% interconnecting pore to 
maximize the diffusion and exchange 
of nutrients. Sufficient mechanical 
strength is also a crucial property of 
the scaffold. Scaffolding approaches 
such as the pre-made porous scaffold, 
the decellularised extracellular 
matrix, cell sheets with a secreted 
extracellular matrix, cells encapsulated 
in a self-assembled hydrogel, and rapid 
prototyping can be used to produce 
more reliable and functional scaffolds 
for dental tissue engineering.  With the 
emergence of tissue engineering, the 
development of scaffold from various 
sources, designs, and properties has 
shed new light on the treatment 
of patients with dental diseases. 
Advances in dental tissue engineering 
may become available for clinical 
application. However, one of the 
challenges in realizing this idea is the 
aggregate cost required to introduce 
such technology to clinicians and 
patients. Therefore, the production of 
affordable, reproducible, and clinically-
safe scaffolds should be considered so 
that this technology could become 
accessible to all clinician as well as the 
patient. Moreover, advanced research 
in scaffolds with tissue-specific 
considerations in relation to target 
tissue composition and interfaces, 
structural, and functional relationships 
deserves more attention among 
researchers.
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